160 related articles for article (PubMed ID: 11289733)
21. Conditional BRAFV600E expression induces DNA synthesis, apoptosis, dedifferentiation, and chromosomal instability in thyroid PCCL3 cells.
Mitsutake N; Knauf JA; Mitsutake S; Mesa C; Zhang L; Fagin JA
Cancer Res; 2005 Mar; 65(6):2465-73. PubMed ID: 15781663
[TBL] [Abstract][Full Text] [Related]
22. [Fetal cell carcinogenesis hypothesis and its impact on clinical pathology of cancer].
Takano T
Rinsho Byori; 2008 May; 56(5):402-8. PubMed ID: 18546890
[TBL] [Abstract][Full Text] [Related]
23. Chromosomal aberrations in thyroid follicular-cell neoplasia: in the search of novel oncogenes and tumour suppressor genes.
Zitzelsberger H; Thomas G; Unger K
Mol Cell Endocrinol; 2010 May; 321(1):57-66. PubMed ID: 19961897
[TBL] [Abstract][Full Text] [Related]
24. Molecular alterations associated with bladder cancer initiation and progression.
Cordon-Cardo C
Scand J Urol Nephrol Suppl; 2008 Sep; (218):154-65. PubMed ID: 18815930
[TBL] [Abstract][Full Text] [Related]
25. [Origin and progression of thyroid epithelial tumors: molecular and cellular mechanisms].
Gire V; Wynford-Thomas D
Arch Anat Cytol Pathol; 1998; 46(1-2):11-8. PubMed ID: 9754356
[TBL] [Abstract][Full Text] [Related]
26. Frequent epigenetic silencing of the CpG island promoter of RASSF1A in thyroid carcinoma.
Schagdarsurengin U; Gimm O; Hoang-Vu C; Dralle H; Pfeifer GP; Dammann R
Cancer Res; 2002 Jul; 62(13):3698-701. PubMed ID: 12097277
[TBL] [Abstract][Full Text] [Related]
27. Expression of the sodium iodide symporter and thyroglobulin genes are reduced in papillary thyroid cancer.
Ringel MD; Anderson J; Souza SL; Burch HB; Tambascia M; Shriver CD; Tuttle RM
Mod Pathol; 2001 Apr; 14(4):289-96. PubMed ID: 11301345
[TBL] [Abstract][Full Text] [Related]
28. [Cellular oncogenes and antioncogenes in thyroid tumors].
Abrosimov AIu
Arkh Patol; 1997; 59(1):64-9. PubMed ID: 9139613
[TBL] [Abstract][Full Text] [Related]
29. Epigenetic dysregulation in thyroid neoplasia.
Kondo T; Asa SL; Ezzat S
Endocrinol Metab Clin North Am; 2008 Jun; 37(2):389-400, ix. PubMed ID: 18502333
[TBL] [Abstract][Full Text] [Related]
30. Molecular classification and biomarker discovery in papillary thyroid carcinoma.
Sheils O
Expert Rev Mol Diagn; 2005 Nov; 5(6):927-46. PubMed ID: 16255634
[TBL] [Abstract][Full Text] [Related]
31. Recent developments in the clinical application of thyroid cancer biomarkers.
Shibru D; Chung KW; Kebebew E
Curr Opin Oncol; 2008 Jan; 20(1):13-8. PubMed ID: 18043251
[TBL] [Abstract][Full Text] [Related]
32. Thyroid tumor marker genomics and proteomics: diagnostic and clinical implications.
Carpi A; Mechanick JI; Saussez S; Nicolini A
J Cell Physiol; 2010 Sep; 224(3):612-9. PubMed ID: 20578236
[TBL] [Abstract][Full Text] [Related]
33. Genetic background of carcinogenesis in the thyroid gland.
Lewiński A; Wojciechowska K
Neuro Endocrinol Lett; 2007 Apr; 28(2):77-105. PubMed ID: 17435680
[TBL] [Abstract][Full Text] [Related]
34. Thyrotropin receptor: a role for thyroid tumourigenesis?
Russo D; Arturi F; Chiefari E; Filetti S
Forum (Genova); 1999; 9(2):166-75. PubMed ID: 10385711
[TBL] [Abstract][Full Text] [Related]
35. Molecular genetic study comparing follicular variant versus classic papillary thyroid carcinomas: association of N-ras mutation in codon 61 with follicular variant.
Di Cristofaro J; Marcy M; Vasko V; Sebag F; Fakhry N; Wynford-Thomas D; De Micco C
Hum Pathol; 2006 Jul; 37(7):824-30. PubMed ID: 16784981
[TBL] [Abstract][Full Text] [Related]
36. Molecular basis of epithelial tumorigenesis: the thyroid model.
Wynford-Thomas D
Crit Rev Oncog; 1993; 4(1):1-23. PubMed ID: 8416149
[TBL] [Abstract][Full Text] [Related]
37. Origin and progression of thyroid epithelial tumours: cellular and molecular mechanisms.
Wynford-Thomas D
Horm Res; 1997; 47(4-6):145-57. PubMed ID: 9167946
[TBL] [Abstract][Full Text] [Related]
38. Progress in thyroid cancer.
Kaplan MM
Endocrinol Metab Clin North Am; 1990 Sep; 19(3):469-78. PubMed ID: 2261903
[TBL] [Abstract][Full Text] [Related]
39. Pathogenesis of thyroid nodules: histological classification?
Salabè GB
Biomed Pharmacother; 2001 Feb; 55(1):39-53. PubMed ID: 11237284
[TBL] [Abstract][Full Text] [Related]
40. Molecular genetics of thyroid tumors and surgical decision-making.
Learoyd DL; Messina M; Zedenius J; Robinson BG
World J Surg; 2000 Aug; 24(8):923-33. PubMed ID: 10865036
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
